Drug Profile

P 3914

Alternative Names: P3914

Latest Information Update: 16 Jul 2016

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Piramal Life Sciences
Developer Piramal Enterprises
Class Naphthaleneacetic acids; Nonsteroidal anti-inflammatories; Small molecules
Mechanism of Action Cyclooxygenase inhibitors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

16 Jul 2016 No recent reports of development identified for phase-I development in Dental-pain in India (PO, Tablet)
21 Nov 2012 Piramal Healthcare terminates a phase I trial in Dental pain in India (NCT01339156)
11 Apr 2012 Piramal Life Sciences suspends enrolment in its phase I trial for Dental pain in India

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com